Harvard Bioscience, Inc. (HBIO) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Harvard Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.852 Good day and welcome to the second quarter, 2026 Harvard Bioscience Earnings Conference 00:00:04.852 -- 00:00:08.793 call. At this time, all participants are in listen-only mode. 00:00:08.793 -- 00:00:12.414 After the speaker's presentation, there will be a question and answer session. 00:00:12.414 -- 00:00:16.655 To ask a question, you will need to press star 1-1 on your touchstone telephone. 00:00:16.655 -- 00:00:20.676 Please note this call is being recorded. I would like to turn the call over to Taylor 00:00:20.676 -- 00:00:23.337 Krafchick, Senior Vice President at Ellipsis. 00:00:23.337 -- 00:00:25.677 Please go ahead. 00:00:25.856 -- 00:00:28.037 Thank you, operator, and good morning, everyone. 00:00:28.037 -- 00:00:31.518 Thank you for joining the Harvard Bioscience Second Quarter 2026 Earnings Conference 00:00:31.518 -- 00:00:36.781 Call. Leading the call today will be John Duke, President and Chief Executive Officer, 00:00:36.781 -- 00:00:41.162 and Mark Frost, Chief Financial Officer. In conjunction with today's recorded call, we 00:00:41.162 -- 00:00:44.644 have provided a presentation that will be referenced during our remarks that is posted 00:00:44.644 -- 00:00:48.985 to our investor relations section of our website at investor.harvardbioscience.com. 00:00:50.106 -- 00:00:53.484 Please note that statements made in today's discussion that are not historical facts, 00:00:53.484 -- 00:00:57.086 including statements on management's expectations of future events or future financial 00:00:57.086 -- 00:01:00.849 performance, are forward-looking statements and are made pursuant to the safe harbor 00:01:00.849 -- 00:01:05.172 provisions of the Private Securities Litigation Reform Act of 1995. 00:01:05.172 -- 00:01:08.754 Thes...